Swiss Re is engaged in wholesale reinsurance, insurance and risk transfer solutions. Co.'s clients include insurance companies, corporations, the public sector and policyholders. Co.'s business units include: Property & Casualty Reinsurance, which includes the business lines property and casualty (including motor); Life & Health Reinsurance, which includes the life and health line of business; Corporate Solutions, which serves mid-sized and large corporations, with product offerings ranging from property and casualty insurance to customised solutions; and Admin Re®, which provides risk and capital management solutions.
  • TickerRUKN
  • ISINCH0126881561
  • ExchangeSix Swiss Exchange
  • SectorNonlife Insurance
  • CountrySwitzerland

Analysts

1 director sold

A director at Swiss Re Ag sold 7,109 shares at 99.080CHF and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board me...

Swiss Re

Henry Heathfield

Morningstar | Swiss Re 1Q Shares Expensive

Swiss reported first-quarter net income of $430 million, slightly ahead of our expectations. Though investors should be aware that this is typically a light claims quarter. Swiss Re's corporate solutions is still in loss. We maintain our CHF 84 fair value estimate and no-moat rating. The brightest part of the release is that life and health reinsurance posted a net profit of $330 million, which is almost unheard of for this business. If Swiss Re can keep tracking this and deliver a normal nonlife result, full-years earning should be impressive. However, we are skeptical of this due to the mag...

Henry Heathfield

Swiss Re 1Q Shares Expensive

Swiss reported first-quarter net income of $430 million, slightly ahead of our expectations. Though investors should be aware that this is typically a light claims quarter. Swiss Re's corporate solutions is still in loss. We maintain our CHF 84 fair value estimate and no-moat rating. The brightest part of the release is that life and health reinsurance posted a net profit of $330 million, which is almost unheard of for this business. If Swiss Re can keep tracking this and deliver a normal nonli...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Int'l Compass: Global Equity Strategy

EU and UK Financials remain actionable Our outlook on global equities (both the MSCI ACWI and ACWI ex-US) remains positive and we continue to expect higher equity prices going forward. Below we highlight several new developments which give us additional confidence in our outlook, including but not limited to continued price and RS improvements for UK/European Financials. • Actionable Sector: Financials. Today's stock recommendations go beyond UK and European Financials, however these regions are the primary focus due to a plethora of attractive setups. In today's report we reiterate our 3/21...

Henry Heathfield

Morningstar | Swiss Re 1Q Shares Expensive

Swiss reported first-quarter net income of $430 million, slightly ahead of our expectations. Though investors should be aware that this is typically a light claims quarter. Swiss Re's corporate solutions is still in loss. We maintain our CHF 84 fair value estimate and no-moat rating. The brightest part of the release is that life and health reinsurance posted a net profit of $330 million, which is almost unheard of for this business. If Swiss Re can keep tracking this and deliver a normal nonlife result, full-years earning should be impressive. However, we are skeptical of this due to the mag...

Henry Heathfield

Swiss Re 1Q Shares Expensive

Swiss reported first-quarter net income of $430 million, slightly ahead of our expectations. Though investors should be aware that this is typically a light claims quarter. Swiss Re's corporate solutions is still in loss. We maintain our CHF 84 fair value estimate and no-moat rating. The brightest part of the release is that life and health reinsurance posted a net profit of $330 million, which is almost unheard of for this business. If Swiss Re can keep tracking this and deliver a normal nonli...

Henry Heathfield

Morningstar | Swiss Re Full-Year 2018: Outlook Remains Uncertain for Corporate Solutions

Swiss Re reported net income for full-year 2018 of CHF 420 million post CHF 3.0 billion of large claims. This is well below our long-term estimate for the long-term earnings of the business. While the net income number includes USD 600 million for a U.S. GAAP accounting change impact, we are lowering our fair value estimate to CHF 84.0 to account for a generally lower level of pricing improvement within non-life reinsurance and a remaining poor environment for corporate solutions. We maintain our no-moat rating. The property and casualty combined ratio of 104 percent is equal to 2011, a terri...

Henry Heathfield

Morningstar | Swiss Re Full-Year 2018: Outlook Remains Uncertain for Corporate Solutions. See Updated Analyst Note from 04 Mar 2019

Swiss Re reported net income for full-year 2018 of CHF 420 million post CHF 3.0 billion of large claims. This is well below our long-term estimate for the long-term earnings of the business. While the net income number includes USD 600 million for a U.S. GAAP accounting change impact, we are lowering our fair value estimate to CHF 84.0 to account for a generally lower level of pricing improvement within non-life reinsurance and a remaining poor environment for corporate solutions. We maintain our no-moat rating. The property and casualty combined ratio of 104 percent is equal to 2011, a terri...

Henry Heathfield

Swiss Re Full-Year 2018: Outlook Remains Uncertain for Corporate Solutions

Swiss Re reported net income for full-year 2018 of CHF 420 million post CHF 3.0 billion of large claims. This is well below our long-term estimate for the long-term earnings of the business. While the net income number includes USD 600 million for a U.S. GAAP accounting change impact, we are lowering our fair value estimate to CHF 84.0 to account for a generally lower level of pricing improvement within non-life reinsurance and a remaining poor environment for corporate solutions. We maintain ou...

1 director sold

A director at Swiss Re Ag sold 7,109 shares at 99.080CHF and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board me...

Swiss Re

With a more favourable environment, SWISS RE AG improves to Slightly Positive

SWISS RE AG (CH), a company active in the Reinsurance industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date January 18, 2019, the closing price was CHF 94.90 and its potential was estimated at CHF 99.65.

Swiss Re

Swiss Re

Swiss Re

Swiss RE – Proxinvest Corporate Governance Rating ® : C

Proxinvest Corporate Governance Rating ® helps investors integrate governance into their investment decision and identify governance risks and opportunities within their portfolio. Proxinvest Corporate Governance Rating ® Service rates European issuers through the analysis of four main themes : Ownership & Shareholder rights, Board & Committees, Audit & Process, Remuneration. Each theme is rated taking into account several comprehensive sub-categories. Our unique two-step process to achieve each rating includes a first step quantitative valuation and a second step qualitative filter...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Int'l Compass: Global Equity Strategy

EU and UK Financials remain actionable Our outlook on global equities (both the MSCI ACWI and ACWI ex-US) remains positive and we continue to expect higher equity prices going forward. Below we highlight several new developments which give us additional confidence in our outlook, including but not limited to continued price and RS improvements for UK/European Financials. • Actionable Sector: Financials. Today's stock recommendations go beyond UK and European Financials, however these regions are the primary focus due to a plethora of attractive setups. In today's report we reiterate our 3/21...

Matthieu DRIOL

Analyse court terme - SWISS RE AG : Les cours progressent encore.

La tendance est haussière. Les cours progressent encore, mais la tendance s'affaiblit. La prochaine résistance est à 93,32 CHF. La rupture de 86,24 CHF mettrait la tendance en danger.

Matthieu DRIOL

Short term view - SWISS RE AG : Prices are still making progress.

The trend is bullish. Prices are still making progress but the trend is slowing down. The next resistance is at CHF 93.32. The break of CHF 86.24 would endanger the trend.

Matthieu DRIOL

Analyse court terme - SWISS RE AG : La tendance est haussière.

La tendance est haussière. La baisse récente gagne en vigueur. Le prochain support est à 86,24 CHF. La tendance serait remise en cause par la rupture de 86,24 CHF.

Matthieu DRIOL

Short term view - SWISS RE AG : The trend is bullish.

The trend is bullish. The recent fall is getting more vigorous. The next support is at CHF 86.24. A break below CHF 86.24 would challenge the trend.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch